A blood test to monitor anticoagulation therapy for patients taking heparin isSelect one:a.C-reactive protein.b.activated partial thromboplastin time.c.lipid profile.d.creatine phosphokinase.Clear my choice
Question
A blood test to monitor anticoagulation therapy for patients taking heparin isSelect one:a.C-reactive protein.b.activated partial thromboplastin time.c.lipid profile.d.creatine phosphokinase.Clear my choice
Solution
The correct answer is b. activated partial thromboplastin time.
Here's why:
a. C-reactive protein: This is a protein made by the liver and sent into the bloodstream in response to inflammation. It's not used to monitor anticoagulation therapy.
b. Activated partial thromboplastin time (aPTT): This is a test that measures the time it takes for your blood to clot. It's used to monitor how well heparin therapy is working to prevent blood clots.
c. Lipid profile: This is a group of tests that are often ordered together to determine risk of coronary heart disease. They are not used to monitor anticoagulation therapy.
d. Creatine phosphokinase: This is an enzyme found mainly in the heart, brain, and skeletal muscle. It is tested in the blood to measure the amount of damage to these muscles. It's not used to monitor anticoagulation therapy.
Similar Questions
Select the correct statements. (Note that there may be more than one correct statement.)Group of answer choicesThrombolytic substances dissolve existing blood clots but cannot prevent their formation.Heparin cannot be absorbed from the gastrointestinal tract and therefore it is an injectable anticoagulant.One of the reasons Warfarin should not be administered in pregnancy is that it crosses the placenta and therefore may cause cerebral haemorrhage in the fetus during delivery.Heparin and warfarin effectively inhibit platelet aggregation.
A nurse is caring for a 39-year-old female client on a medical-surgical floor. The interdisciplinary team has determined that the client is at a risk for the development of a pulmonary embolism and has therefore implemented prophylactic measures. The client is prescribed Warfarin therapy for its anticoagulant effects. Based on the nurse's understanding of the drug, the nurse confirms that the drug has reached a therapeutic level when which of the following coagulation results are obtained?The client's baseline coagulation studies:Activated partial thromboplastin time (aPTT): 30 secondsInternational normalized ratio (INR): 1.5Prothrombin time (PT): 10 secondsCassidy RhodyID: 112703Question 6Select one:1.PT 7 seconds, INR 2.52.PT 19 seconds, INR 2.03.PT 25 seconds, INR 2.14.aPTT 35 seconds, INR 3.0
How does heparin prevent the clotting of blood?Multiple ChoiceBy binding to calcium ionsBy depleting the blood of plateletsBy inhibiting the formation of prothrombin activator and the action of thrombin on fibrinogenBy interfering with the formation of thrombin and fibrinogen
A client has refused a prescribed injection of subcutaneous heparin. Which initial action should the nurse take?A. Document the refusalB. Notify the primary healthcare provider (PHCP)C. Review the client's most recent platelet countD. Inquire with the client about the refusal
This oral anticoagulant is slow acting and typically given along with heparin for 5-7 days. Group of answer choicesWarfarin (coumadin)alteplasestreptokinaseheparin
Upgrade your grade with Knowee
Get personalized homework help. Review tough concepts in more detail, or go deeper into your topic by exploring other relevant questions.